Skip to main content

Shortage of Menopause Hormone Therapy - 22 May 2020

The Therapeutic Goods Administration (TGA) has advised that there are currently and/or anticipated shortages of various doses of Estradot, Estalis Sequi and Climara patches in Australia.

Please see information here:

Supply of Estraderm, Sandrena and Estrogel have not been affected and may be good alternatives for Estradot and Climara. If substituting Estraderm, Sandrena or Estrogel for Estalis Sequi, a progestogen will need to be added. Please see the AMS Guide to Equivalent MHT/HRT Doses to review the alternative options available.

There are also shortages of Angeliq and Duavive. Alternative options are available for these (such as Femonston-Conti, Kliovance, Estrogel Pro, Livial, Xyvion and Kliogest) so please check the AMS Guide to Equivalent MHT/HRT Doses to review alternative options.

Patients who are having issues with filling their prescription are encouraged to see their doctors to discuss alternative options.

Content created 22 May 2020